Plasma levels of 8-epiPGF2α, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer's disease

Free Radical Biology and Medicine

Volumn 27, Issue 3-4, 1999, Pages 463-469

  Feillet Coudray, Christine ^a   Tourtauchaux, Rémi ^b   Niculescu, Michel ^a   Rock, Edmond ^a   Tauveron, Igor ^c   Alexandre Gouabau, Marie Cecile ^a   Rayssiguier, Yves ^a   Jalenques, Isabelle ^b   Mazur, Andrzej ^a  

^a CRNH AUVERGNE   (France)

^b CH Sainte Marie   (France)

^c INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Aging; Alzheimer's disease; Antioxidant status; Free radicals; Isoprostanes

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ANTIOXIDANT; FREE RADICAL; ISOPROSTANE;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CANCER; CELL FUNCTION; FEMALE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; DINOPROST; FEMALE; FREE RADICALS; HUMANS; LINEAR MODELS; LIPID PEROXIDATION; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OXIDATIVE STRESS;

EID: 0032866415     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(99)00096-9     Document Type: Article

References (42)

1. Yu B.P. Aging and oxidative stress modulation by dietary restriction . Free Radic. Biol. Med. 21:1996;651-668.
2. Harman D. The free radical theory of aging. Pryor A. Free radicals in biology. (5th ed). 1984;255-275 Academic Press, New York.
3. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine. (2nd ed). 1989;Clarendon Press, Oxford.
4. Morrow J.D., Hill K.H., Burk R.F., Nammour T.M., Badr K.F., Jackson Roberts L. II. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA. 87:1990;9383-9387.
5. Lynch S.M., Morrow J.D., Jackson Roberts L. II, Frei B. Formation of a non-cyclooxigenase-derived prostanoids in plasma and low density lipoprotein exposed to oxidative stress in vivo. J. Clin. Invest. 93:1994;998-1004.
6. Jackson Roberts L. II, Morrow J.D. The generation and actions of isoprostanes. Biochim. Biophys. Acta. 1345:1997;121-135.
7. Morrow J.D., Jackson Roberts L. The isoprostanes unique bioactive products of lipid peroxidation . Prog. Lipid Res. 36:1997;1-21.
8. Rokach J., Khanapure S.P., Hwang S.W., Adiyaman M., Lawson J.A., Fitzgerald G.A. The isoprostanes a perspective . Prostaglandins. 54:1997;823-851.
9. Diagnostic and statistical manual of mental disorders. (4th ed). 1994;American Psychiatric Association, Washington, DC.
10. Kakkar R., Mantha S.V., Radhi J., Prasad K., Kalra J. Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. J. Clin. Sci. 94:1998;623-632.
11. Morrow J.D., Awad J.A., Boss H.J., Blair I.A., Roberts L.J. Non cyclo-oxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. USA. 89:1992;10721-10725.
12. Gueux E., Azais-Braesco V., Bussière L., Grolier P., Mazur A., Rayssiguier Y. Effect of magnesium deficiency on triacylglycerol-rich lipoprotein and tissue susceptibility to peroxidation in relation to vitamin E content. J. Nutr. 126:1996;2550-2556.
13. Whitehead T.P., Thorpe G.H.G., Maxwell S.R.J. Enhanced chemiluminescent assay for antioxidant-capacity in biological fluids. Anal. Chim. Acta. 266:1992;265-277.
14. Sivakumar B., Jahoor F., Burrin D.G., Frazer E.M., Reeds P.J. Fractional synthesis rates of retinol-binding protein and transthyretin and a new peptide measured by a stable isotope techniques in neonatal pigs. J. Biol. Chem. 269:1994;26196-26200.
15. Wang Z., Ciabattoni G., Cremino C., Lawson J., Fitzgerald G.A., Patrono C., Maclouf J. Immunological characterization of urinary 8-epi-prostaglandin F2alpha excretion in man. J. Pharmacol. Exp. Ther. 275:1995;94-100.
16. Rice-Evans C., Miller N.J. Total antioxidant status in plasma and body fluids. Meth. Enzymol. 234:1994;279-293.
17. Valkonen M., Kuusi T. Sepctrophotometric assay for total peroxyl radical-trapping antioxidant potential in human serum. J. Lipid Res. 38:1997;823-833.
18. Ghisolfi-Marque A., Boyer M.A., Vella B., Thouvenot J.P., Albarède L., Ghisolfi J. Activité anti-oxydante, lipoperoxydation et vieillissement chez l'homme. Nutr. Clin. Metabol. 10:1996;151-160.
19. Rodriguez-Martinez M.A., Ruiztorres A. Homeostasis between lipid peroxidation and antioxidant enzyme activities in healthy human aging. Med. Aging Dev. 66:1992;213-222.
20. Reddy K.K., Ramachandraiah T., Kumari K.S., Redanna P., Thiagaraju K. Serum lipid peroxidation and antioxidant defence components of rural and urban populations and aging. Age. 16:1993;9-14.
21. Coudray C., Roussel A.M., Mainard F., Arnaud J., Favier A. Lipid peroxidation level and antioxidant micronutrient status in a pre-aging population; correlation with chronic disease prevalence in a French epidemiological study (Nantes, France). J. Am. Coll. Nutr. 16:1997;584-591.
22. Rondanelli M., Melzi d'Evril G.V., Anesi A., Ferrari E. Altered oxidative stress in healthy old subjects. Aging. 9:1997;221-223.
23. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA. 90:1993;7915-7922.
24. Harrington C.R., Colaco C.A.L.S. Alzheimer's disease - a glycation connection. Nature. 370:1994;247-248.
25. Hoyer S. Abnormalities of glucose metabolism in Alzheimer's disease. Ann. N.Y. Acad. Sci. 640:1991;53-58.
26. Meier-Ruge W., Bertoni-Freddari C., Inrangoff P. Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease. Gerontology. 40:1994;246-252.
27. Mattson M.P. Calcium and neuronal changes injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism free radicals and metabolic compromises. Ann. NY Acad. Sci. 747:1994;50-76.
28. Bauer J., Berger M. Neuropathological immunologic and psychological aspects of Alzheimer's dementia. Forschr. Neurol. Psychiatr. 61:1993;225-240.
29. Reinikainen K., Soininen H., Riekkinen P.J. Neurotransmitter changes in Alzheimer's disease implication to diagnostics and therapy . J. Neurosci. Res. 27:1990;576-586.
30. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:1997;134-147.
31. Marcus D.L., Thomas C., Rodriguez C., Simberkoff K., Tsai J.S., Strafaci J.A., Freedman M.L. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp. Neurol. 150:1998;40-44.
32. Markesbery W.R., Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging. 19:1998;33-36.
33. Lyras L., Cairns N.J., Jenner A., Halliwell B. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68:1997;2061-2069.
34. Jeandel C., Nicolas M.B., Dubois F., Nabet-Belleville F., Penin F., Cuny G. Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology. 35:1989;275-282.
35. Roberts L.J. II, Montine T.J., Markesbery W.R., Tapper A.R., Hardy P., Chemtob S., Dettbarn W.D., Morrow J.D. Formation of isoprostane-like compounds (neuroprostanes) invivo from docosahexaenoic acid. J. Biol. Chem. 273:1998;13605-13612.
36. Pratico D., Lee V.M.-Y., Trojanowski J.Q., Rokach J., Fitzgerald G.A. Increased F2-isoprostanes in Alzheimer's disease evidence for enhanced lipid peroxidation in vivo . FASEB J. 12:1998;1777-1783.
37. Montine T.J., Beal M.F., Cudkowicz M.E., O'Donnell H., Margolin R.A., McFarland L., Bachrach A.F., Zackert W.E., Roberts L.J., Morrow J.D. Increased CSF F2-isoprostane concentration in probable AD. Neurology. 52:1999;562-565.
38. Ceballos-Picot I., Mansouria M.B., Nicole A., Thevenin M., Helliet G., Legrain S., Berr C. Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type - place of the extracellular glutathione peroxidase. Free Radic. Biol. Med. 20:1996;579-587.
39. Ihara Y., Hayabara T., Sasaki K., Fujisawa Y., Kawada R., Yamamoto T., Nakashima Y., Yoshimune S., Kawai M., Kibata M., Kuroda S. Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia. J. Neurol. Sci. 153:1997;76-81.
40. Bermejo P., Gomez-Serranillos P., Santos J., Pastor E., Gil P., Martin-Aragon S. Determination of malonaldehyde in Alzheimer's disease: a comparative study of high-performance liquid chromatography and thiobarbituric acid test. Gerontology. 43:1997;218-222.
41. Thome J., Gsell W., Kornhuber J., Frolich L., Hashimoto E., Zielke B., Wiesbeck G.A., Riederer P. Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer's disease. Life Sci. 60:1997;13-19.
42. De Leo M.E., Borrelo S., Passantino M., Palazotti B., Mordente A., Daniele A., Filippini V., Galeotti T., Masullo C. Oxidative stress and overexpression of manganese superoxide dismutase in patients with Alzheimer's disease. Neurosci. Lett. 250:1998;173-176.